Indian CDMO Yapan Bio has landed an investment from Piramal Pharma, the company announced, to help enhance its manufacturing arm. Yapan provides biologic and vaccine scale-up and manufacturing…
A low-profile small interfering RNA player has managed to squeeze in its IPO before the year ends, adding another listing to the Hong Kong stock exchange’s tally. Sirnaomics is making its HKEX debut…
Johnson & Johnson has shipped bispecific multiple myeloma candidate teclistamab off to the FDA for a potential approval. Bispecifics have been getting a lot of buzz—and cash—from the Big Pharma crowd…
Scientists at the University of Michigan describe a novel PROTAC degrader of a protein nexus that several cancer-promoting genes depend on to drive prostate cancer. In mouse models, the drug showed…
The FDA authorized its second major self-diagnostic in less than a week, while the Department of Defense inked a multimillion-dollar contract to set up a new plant for manufacturing rapid testing…
MedCity Influencers, Health Tech, Patient Engagement In the post-pandemic world, care teams–from providers to insurers – must increase personalization and reduce complexity to empower consumers to engage more in their health and drive better care outcomes. https://medcitynews.com/author/kbravo
While hospitals are slow to comply with the price transparency rules, full compliance will eventually mean hospitals provide ‘machine readable files’ with thousands of lines of pricing data.
Experts say the U.S. has a ways to go to get through the Omicron surge. Here, STAT outlines what Omicron is already teaching us as this phase of the pandemic plays out.
In the post-pandemic world, care teams–from providers to insurers – must increase personalization and reduce complexity to empower consumers to engage more in their health and drive better care…
A jury held Teva Pharmaceuticals responsible Thursday for contributing to the opioid crisis, delivering a verdict in a sweeping lawsuit filed by New York state.
